Optic Nerve Injuries D020221

Related MeSH Hierarchy (5)

Diseases [C] » Nervous System Diseases [C10] » Cranial Nerve Diseases » Cranial Nerve Injuries » Optic Nerve Injuries

Diseases [C] » Nervous System Diseases [C10] » Cranial Nerve Diseases » Optic Nerve Diseases » Optic Nerve Injuries

Diseases [C] » Nervous System Diseases [C10] » Trauma, Nervous System » Craniocerebral Trauma » Cranial Nerve Injuries » Optic Nerve Injuries

Diseases [C] » Eye Diseases [C11] » Optic Nerve Diseases » Optic Nerve Injuries

Diseases [C] » Wounds and Injuries [C26] » Trauma, Nervous System » Craniocerebral Trauma » Cranial Nerve Injuries » Optic Nerve Injuries

Description

Injuries to the optic nerve induced by a trauma to the face or head. These may occur with closed or penetrating injuries. Relatively minor compression of the superior aspect of orbit may also result in trauma to the optic nerve. Clinical manifestations may include visual loss, PAPILLEDEMA, and an afferent pupillary defect.   MeSH

Hierarchy View

Subtype Terms (1)

Toxic Optic Neuropathy
3 drugs (2 approved, 1 experimental)


Phase 3 Indicated Drugs (1)

Phase 2 Indicated Drugs (1)

Phase 1 Indicated Drugs (1)

Other Experimental Indicated Drugs (1)


Organization Involved with Phase 1 Indications (1)

Organization Involved with Other Experimental Indications (2)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.